Canon Receives FDA Clearance for AI-Fueled MRI Technology

Canon’s medical unit has just hit a new milestone.

The Japanese imaging and optical products giant recently announced that Canon Medical Systems USA has just received clearance from the U.S. Food and Drug Administration for its Advanced intelligent Clear-IQ Engine (AiCE).

The clearance allows Canon to integrate AiCE with Vantage Galan 3T MR system, allowing it to use deep learning to make clearer, sharper, and more distinct MRIs. This, the company says, further opens doors for advancements in MR imagine.

AiCe purportedly allows for “the differentiation of true signal from noise through deep learning,” letting it suppress noise while enhancing the signal, thus creating higher quality images. Canon says its fully integrated, too, making for “seamless workflow.”

“AiCE utilizes a next generation approach to MR image reconstruction, further proving Canon Medical’s leadership and commitment to innovation in diagnostic imaging,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc. “With the expansion of this unique DLR method across modalities and into MR, we’re elevating diagnostic imaging capabilities for our customers by bringing the power of AI to routine imaging to provide more possibilities in improving patient care than ever before.”

Photo: Stefan Brending, Lizenz: Creative Commons by-sa-3.0 de